Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival (Q35103474)

6 August 2017

Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival (English)

1 reference

6 August 2017

1 reference

5

Richard A Gibbs

1 reference

6 August 2017

Donghui Li

1

1 reference

6 August 2017

Motofumi Tanaka

2

1 reference

6 August 2017

F Charles Brunicardi

3

1 reference

6 August 2017

William E Fisher

4

1 reference

6 August 2017

Marie-Claude Gingras

6

1 reference

6 August 2017

language of work or name

English

0 references

publication date

10 January 2011

1 reference

6 August 2017

1 reference

6 August 2017

117

1 reference

6 August 2017

13

1 reference

6 August 2017

2863-2872

1 reference

Epidemiology of pancreatic cancer: an overview

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Body mass index and risk, age of onset, and survival in patients with pancreatic cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

9 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

F-SNP: computationally predicted functional SNPs for disease association studies

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Risk factors for pancreatic cancer: case-control study

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Assessing the probability that a positive report is false: an approach for molecular epidemiology studies

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Insulin-like growth factor-I: compartmentalization within the somatotropic axis?

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Role of the insulin-like growth factor family in cancer development and progression

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Mechanisms of antineoplastic action of somatostatin analogs

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

The somatostatin receptor family.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135720

Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.

9 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25858

Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25858

Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25858

Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25858

Genetic Variation in the Growth Hormone Synthesis Pathway in Relation to Circulating Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Breast Cancer Risk: Results from the European Prospective Investigation into Cancer a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25858

Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21692047

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Somatuline (BIM 23014) and tamoxifen treatment of postmenopausal breast cancer patients: clinical activity and effect on insulin-like growth factor-I (IGF-I) levels

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21692047

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CNCR.25858

1 reference

6 August 2017

1 reference

6 August 2017

1 reference